Navigating the Future of Clinical Trials: Understanding the draft Annex 2 document of the ICH E6 (R3) GCP Guidelines
Wed, 22 Jan
|CHI Auditorium, Level 4
Join us for an insightful forum, led by Ms Sumitra Sachidanandan, where we will delve into the draft Annex 2 document, focusing on additional GCP considerations for interventional clinical trials and explore their implications for the future of clinical research.
Time & Location
22 Jan 2025, 3:00 pm โ 5:00 pm
CHI Auditorium, Level 4, 18 Jln Tan Tock Seng, Singapore 308443
About the event
The clinical trial landscape is evolving rapidly, and with the upcoming ICH E6(R3) Good Clinical Practice (GCP) guideline, the global standards for clinical trials are set to be transformed.
Once published, the revised ICH E6 (R3) GCP guideline will comprise the following documents:
Principles document
Annex 1 โ Considerations for Interventional Clinical Trials
Annex 2 โ Additional Considerations for Interventional Clinical Trials